相关实验视频
Updated: Sep 20, 2025

07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
43.9K
药物,物理和水疗计划在减少高血压患者内皮功能障碍方面的贡献
Roxana Cristina Rad Bodan1,2,3, Adina Octavia Dușe4, Eniko Gabriela Papp2
1Doctoral School, Victor Babeş University of Medicine and Pharmacy, No. 2 Eftimie Murgu Square, 300041 Timișoara, Romania.
Journal of functional morphology and kinesiology
|May 23, 2025
概括
与心血管康复计划相结合的抗高血压药物显著改善了高血压患者的血压和内皮功能障碍标志物. 仅仅生活方式建议对高血压管理的益处有限.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 康复医学 康复医学 康复医学
背景情况:
- 高血压是欧洲的主要心血管疾病,全球治疗率低于最佳水平.
- 内皮功能障碍是高血压进展的关键指标.
- 有效控制高血压和改善内皮功能是关键的公共卫生目标.
研究的目的:
- 评估抗高血压药物和心血管康复计划 (物理和水疗) 在管理高血压方面的有效性.
- 评估这些干预措施对内皮功能障碍标志物的影响.
- 为了比较高血压的不同治疗策略的有效性.
主要方法:
- 100名1级高血压患者在8周内随机分为四组.
- 组A接受生活方式建议;组B接受生活方式建议和抗高血压药物.
- 组C和D分别接受了生活方式建议,抗高血压药物和物理或水疗心血管计划.
主要成果:
- 组A显示LDL显著下降 (p = 0.002).
- B组在14个参数 (p ≤0.05) 中显著改善.
- 在C组和D组,每组17个参数显著改善 (p ≤ 0.0001),这表明结果优越.
结论:
- 与康复计划 (物理或水疗) 结合的抗高血压药物显著改善了内皮功能障碍标志物和控制血压.
- 包括药物治疗和康复在内的干预措施比单独的生活方式建议产生更好的结果.
- 心血管康复计划增强了抗高血压治疗对高血压管理的益处.
更多相关视频
相关概念视频
Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
Hypertension IV: Drug Therapy and Lifestyle Modifications
57
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
57
Hypertension V: Nursing Management
50
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
50
Peripheral Artery Disease III: Interprofessional Care
36
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
36
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
527
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
527
Atherosclerosis III: Management
44
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
44

